Back to top

STOCKHOLDERS AGREEMENT

Shareholder Agreement

STOCKHOLDERS AGREEMENT | Document Parties: Exhibit 10.15  COMPHEALTH GROUP, INC. | CompHealth Group, Inc. | CMS Capital Ventures, Inc. | HEALTHSOUTH Corporation You are currently viewing:
This Shareholder Agreement involves

Exhibit 10.15 COMPHEALTH GROUP, INC. | CompHealth Group, Inc. | CMS Capital Ventures, Inc. | HEALTHSOUTH Corporation

. RealDealDocs™ contains millions of easily searchable legal documents and clauses from top law firms. Search for free - click here.
Title: STOCKHOLDERS AGREEMENT
Governing Law: Delaware     Date: 3/27/2006

STOCKHOLDERS AGREEMENT, Parties: exhibit 10.15  comphealth group  inc. , comphealth group  inc. , cms capital ventures  inc. , healthsouth corporation
50 of the Top 250 law firms use our Products every day

Exhibit 10.15

COMPHEALTH GROUP, INC.

SECOND AMENDED AND RESTATED

STOCKHOLDERS AGREEMENT

THIS SECOND AMENDED AND RESTATED STOCKHOLDERS AGREEMENT (this “ Agreement ”), is entered into as of March 25, 2003, by and among CompHealth Group, Inc., a Delaware corporation formerly known as CMS Capital Ventures, Inc. (the “ Company ”). HEALTHSOUTH Corporation, a Delaware corporation (“ HEALTHSOUTH ”), each of the investors from time to time listed on the Schedule of Investors attached hereto (collectively, the “ Investors ” and each individually, an “ Investor ”), each of the Executives listed from time to time on the Schedule of Executives attached hereto (collectively, the “ Executives ” and each individually, an “ Executive ”), and each of the warrantholders listed from time to time on the Schedule of Warrantholders attached hereto (collectively, the “ Warrantholders ” and each individually, a “ Warrantholder ”). The Investors, the Executives and the Warrantholders are collectively referred to herein as the “ Stockholders ” and each individually as a “ Stockholder .” Capitalized terms used but not otherwise defined herein are defined in Section 11 hereof.

Certain of the Investors and HEALTHSOUTH (collectively, the “Prior Investors”) hold shares of the Company’s common stock, par value $.01 per share (the “Common Stock”), and the Company’s preferred stock, par value $.01 per share (the “Preferred Stock”). The Executives will purchase shares of Common Stock from time to time upon exercise of options issued to such Executives pursuant to the 1998 Stock Option Plan or any successor stock option plan (the “Stock Option Plan”).

Certain of the Investors are purchasing shares of the Common Stock and Preferred Stock (i) from HEALTHSOUTH pursuant to that certain Stock Purchase Agreement dated as of the date hereof, (ii) from Nassau Capital Partners II L.P. and NAS Partners I L.L.C. pursuant to that certain Stock Purchase Agreement dated as of the date hereof or (iii) from the Company pursuant to that certain Stock Purchase Agreement dated as of the date hereof (collectively, the “ Purchase Agreements ”), and the obligations in the Purchase Agreements are conditioned upon the execution and delivery of this Agreement.

The Company, the Prior Investors, the Executives and the Warrantholders (collectively, the “ Prior Stockholders ”) are parties to an Amended and Restated Stockholders Agreement made as of December 31, 1998 and amended and restated as of March 23, 2000 (the “ Prior Agreement ”). The parties to the Prior Agreement desire to amend and restate the Prior Agreement and accept the rights and covenants hereof in lieu of their rights and covenants under the Prior Agreement.

 

1.


NOW, THEREFORE, in consideration of the mutual covenants contained herein and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties to this Agreement, intending to be legally bound, hereby agree as follows:

1. Board of Directors .

(a) From and after the date hereof and until the provisions of this Section 1 cease to be effective, each Stockholder shall vote all of his or its Stockholder Shares and any other voting securities of the Company over which such Stockholder has voting control and shall take all other necessary or desirable actions within his or its control (whether in the capacity as a stockholder, director, member of a board committee or officer of the Company or otherwise, and including, without limitation, attendance at meetings in person or by proxy for purposes of obtaining a quorum and execution of written consents in lieu of meetings), and the Company shall take all necessary and desirable actions within its control (including, without limitation, calling special board and stockholder meetings), so that:

(i) the authorized number of directors on the Company’s board of directors (the “ Board ”) shall be established at seven (7) directors, or such greater number as is approved by a Supermajority Vote of the Stockholders;

(ii) the following persons shall be elected to the Board:

(A) (1) one (1) representative designated by Stockholders holding a majority of the shares of Common Stock within the Nassau Group (so long as such group is a Qualifying Investor Group); (2) one (1) representative designated by Stockholders holding a majority of the shares of Common Stock within the Acacia Group (so long as such group is a Qualifying Investor Group); (3) one (1) representative designated by Stockholders holding a majority of the shares of Common Stock within the Frazier Group (so long as such group is a Qualifying Investor Group); (4) one (1) representative designated by Stockholders holding a majority of the shares of Common Stock within the NEA Group (so long as such group is a Qualifying Investor Group); and (5) one (1) representative (in addition to the representative designated pursuant to the preceding clause (4)) designated by Stockholders holding a majority of the shares of Common Stock within the NEA Group so long as the NEA Group holds collectively at least 25% of the aggregate Common Stock (on a fully diluted basis) (collectively, the “ Investor Directors ”);

(B) the Company’s chief executive officer (the “ Executive Director ”) (who shall initially be Michael Weinholtz);

(C) one (1) representative that is designated by a Supermajority Vote of the Stockholders and approved by the Executive Director (the “ Outside Director ”); provided that no such Outside Director shall be a member of the Company’s or any Investor’s management or an employee or officer of the Company, any Investor or any of their respective Affiliates; and

(D) if the authorized number of directors on the Board is increased to a number greater than seven (7) in accordance with

 

2.


subsection (i) above, any additional directors shall be representatives that are designated by a Supermajority Vote of the Stockholders (each, a “ Non-Investor Director ”); provided that no such Non-Investor Director shall be a member of any Investor’s management or an employee or officer of any Investor or any Affiliate of an Investor;

(iii) except with respect to CHG Marketing and Technologies Corp., the composition of the board of directors of each of the Company’s subsidiaries (each, a “ Sub Board ”) shall be the same as that of the Board;

(iv) if the Board or any Sub Board forms one or more committees of the Board or such Sub Board, such committee shall, in each case, include at least one Investor Director;

(v) the removal from the Board or a Sub Board (with or without cause) of any Investor Director, the Executive Director, any Outside Director or any Non-Investor Director shall be only upon the written request of the Person or Persons originally entitled to designate such director pursuant to Section 1(a)(ii) above; provided that if the Executive Director ceases to be an employee of the Company and its subsidiaries, he shall be removed as a director promptly after his employment ceases on a date specified by the Supermajority Vote of the Stockholders; provided further that, if any Person or Persons entitled to designate a director pursuant to Section 1(a)(ii) above ceases to have the right to designate such director, such director shall be removed promptly after such Person or Persons cease to have the right to designate such director; and

(vi) in the event that any representative designated hereunder for any reason ceases to serve as a member of the Board or a Sub Board during his or her term of office, the resulting vacancy on the Board or the Sub Board shall be filled by a representative designated by the Person or Persons originally entitled to designate such director pursuant to Section 1(a)(ii) above (so long as such Person or Persons continue to be entitled to designate a director pursuant to Section 1(a)(ii) above); provided that, if such Person or Persons are no longer entitled to designate a director pursuant to Section 1(a)(ii) above, such vacancy shall be filled by a representative designated by a Supermajority Vote of the Stockholders.

(b) There shall be at least four (4) meetings of the Board during every fiscal year, and at least one meeting shall be held in each calendar quarter during the Company’s fiscal year. The Company shall pay all out-of-pocket expenses incurred by each director in connection with attending regular and special meetings of the Board, any Sub Board and any committee thereof.

(c) If any party fails (but is otherwise entitled) to designate a representative to fill a directorship pursuant to the terms of this Section 1, such directorship shall not be filled and the number of directors shall be reduced accordingly; provided that the parties shall take all necessary actions to increase the Board and elect such representative if the party or parties which failed (and are otherwise entitled) to designate such a representative so directs.

 

3.


(d) The provisions of this Section 1 shall terminate automatically and be of no further force and effect upon a Qualified Public Offering.

(e) Notwithstanding anything herein to the contrary, no Warrantholder (except, in the case of any Warrantholder, with respect to any shares of Common Stock issued upon the exercise of the Warrants, and only so long as such shares in the aggregate represent 5% or more of any class of outstanding Stockholder Shares on a fully diluted basis) shall be required to vote its Stockholder Shares or any other voting securities of the Company over which it has voting control in accordance with this Section 1 and no Warrantholder (except to the extent provided in the immediately preceding parenthetical) shall be a party to this Section 1 for purposes of voting such shares in accordance with Section 1(a)(ii).

2. Irrevocable Proxy; Conflicting Agreements .

(a) In order to secure each Executive’s obligation to vote his or her Stockholder Shares and other voting securities of the Company in accordance with the provisions of Sections 1, 7 and 8 hereof, each Executive hereby appoints a representative to be elected from time to time by the Investors holding at least 66 2/3% of the Common Stock held by all Investors (which shall initially be Thomas C. Barnds) as his or her true and lawful proxy and attorney-in-fact, with full power of substitution, to vote all of his or her Stockholder Shares and other voting securities of the Company for the election and/or removal of directors and all such other matters as expressly provided for in Sections 1, 7 and 8 hereof. Such representative may exercise the irrevocable proxy granted to him hereunder at any time such Executive fails to comply with the provisions of this Agreement, and shall vote all securities with respect to which he is exercising his proxy in the same manner and in the same proportion as the Investors. The proxies and powers granted by each Executive pursuant to this Section 2 are coupled with an interest and are given to secure the performance of such Executive’s obligations to the Investors under this Agreement. Such proxies and powers will be irrevocable for the term of this Agreement and will survive the death, incompetency or disability of such Executive and the respective holders of his or her Stockholder Shares and other voting securities of the Company.

(b) Each Stockholder represents that he or it has not granted and is not a party to any proxy, voting trust or other agreement which is inconsistent with or conflicts with the provisions of this Agreement, and no holder of Stockholder Shares shall grant any proxy or become party to any voting trust or other agreement which is inconsistent with or conflicts with the provisions of this Agreement.

3. Financial Statements And Other Information . The Company shall deliver the following to the Stockholder of each Investor Group which holds the largest number of Stockholder Shares (so long as such Investor Group holds any Stockholder Shares), to each holder of at least 10% of the outstanding Stockholder Shares of any class (on a fully-diluted basis) and to the designee of the Warrantholders; provided , however, that the Company shall have no obligation to make any such delivery if the Stockholders waive such delivery requirements by Supermajority Vote:

(a) as soon as available but in any event within 30 days after the end of each monthly accounting period in each fiscal year, unaudited consolidated statements of

 

4.


income and cash flows of the Company and its subsidiaries for such monthly period and for the period from the beginning of the fiscal year to the end of such month, and an unaudited consolidated balance sheet of the Company and its subsidiaries as of the end of such monthly period, setting forth in each case comparisons to the Company’s annual budget and to the corresponding period in the preceding fiscal year, and all such statements shall be prepared in accordance with generally accepted accounting principles, consistently applied, subject to the absence of footnote disclosures and to normal year-end adjustments for recurring accruals, and shall be certified by the Company’s chief financial officer;

(b) within 90 days after the end of each fiscal year, consolidated statements of income and cash flows of the Company and its subsidiaries for such fiscal year, and consolidated balance sheets of the Company and its subsidiaries as of the end of such fiscal year, setting forth in each case comparisons to the Company’s annual budget and to the preceding fiscal year, all prepared in accordance with generally accepted accounting principles, consistently applied, and accompanied by (a) an opinion containing no exceptions or qualifications (except for qualifications regarding specified contingent liabilities) of an independent accounting firm of recognized national standing, (b) a certificate from such accounting firm, addressed to the Company’s board of directors, stating that in the course of its examination nothing came to its attention that caused it to believe that there was any default by the Company or any subsidiary thereof in the fulfillment of or compliance with any of the terms, covenants, provisions or conditions of any other material agreement to which the Company or any subsidiary is a party or, if such accountants have reason to believe any default by the Company or any subsidiary thereof exists, a certificate specifying the nature and period of existence thereof, and (c) a copy of such firm’s annual management letter to the Board;

(c) promptly upon receipt thereof, any additional reports, management letters or other detailed information concerning significant aspects of the Company’s operations or financial affairs given to the Company by its independent accountants (and not otherwise contained in other materials provided hereunder);

(d) at least 30 days but not more than 90 days prior to the beginning of each fiscal year, an annual budget prepared on a monthly basis for the Company and its subsidiaries for such fiscal year (displaying anticipated statements of income and cash flows and balance sheets), and promptly upon preparation thereof any other significant budgets prepared by the Company and any revisions of such annual or other budgets, within 30 days after any monthly period in which there is a material adverse deviation from the annual budget, a letter from the Company’s chief executive officer or chief financial officer explaining the deviation and what actions the Company has taken and proposes to take with respect thereto;

(e) promptly (but in any event within five (5) business days) after the discovery or receipt of notice of any default under any material agreement to which it or any of its subsidiaries is a party or any other material adverse change, event or circumstance affecting the Company or any subsidiary thereof (including, without limitation, the filing of any material litigation against the Company or any subsidiary thereof or the existence of any dispute with any Person which involves a reasonable likelihood of such litigation being commenced), a letter from the Company’s chief executive officer or chief financial officer specifying the nature and period

 

5.


of existence thereof and what actions the Company and its subsidiaries have taken and propose to take with respect thereto;

(f) within ten (10) days after transmission thereof, copies of all financial statements, proxy statements, reports and any other general written communications which the Company sends to its stockholders and copies of all registration statements and all regular, special or periodic reports which it files, or any of its officers or directors file with respect to the Company, with the Securities and Exchange Commission or with any securities exchange on which any of its securities are then listed, and copies of all press releases and other statements made available generally by the Company to the public concerning material developments in the Company’s and its subsidiaries’ businesses; and

(g) with reasonable promptness, such other information and financial data concerning the Company and its subsidiaries as any Person entitled to receive information under this Section 3 may reasonably request.

Each of the financial statements referred to in Section 3(a) and 3(b) above shall fairly present the financial condition and results of operation of the Company as of the dates and for the periods stated therein, subject in the case of the unaudited financial statements to changes resulting from normal year-end adjustments for recurring accruals (none of which would, alone or in the aggregate, be a materially adverse to the financial condition, operating results, assets, operations or business prospects of the Company and its subsidiaries taken as a whole).

Except as otherwise required by law or judicial order or decree or by any governmental agency or authority, each Person entitled to receive information regarding the Company and its subsidiaries under this Section 3 or under Section 4 shall use its best efforts to maintain the confidentiality of all nonpublic information obtained by it hereunder which the Company has reasonably designated as proprietary or confidential in nature; provided that each such Person may, to the extent necessary, disclose such information in connection with the sale or transfer of any Stockholder Shares, if such Person’s transferee agrees in writing to be bound by the provisions hereof.

4. Inspection of Property . The Company shall permit any representatives designated by any Investor Group (so long as such Investor Group holds any Stockholder Shares) or any holder of at least 10% of the outstanding Stockholder Shares of any class upon reasonable notice and during normal business hours to (i) visit and inspect any of the properties of the Company and its subsidiaries, (ii) examine the corporate and financial records of the Company and its subsidiaries and make copies thereof or extracts therefrom and (iii) discuss the affairs, finances and accounts of any such corporations with the directors, officers, key employees and independent accountants of the Company and its subsidiaries. The presentation of an executed copy of this Agreement by any member of an Investor Group or any such holder of Stockholder Shares to the Company’s independent accountants shall constitute the Company’s permission to its independent accountants to participate in discussions with such Persons.

5. Restrictions on Transfer .

(a) [Reserved]

 

6.


(b) Transfer of Stockholder Shares . No Stockholder shall Transfer any interest in any Stockholder Shares or any Warrants, except pursuant to (i) Section 5(e), (ii) Section 7 below, or (iii) a Public Sale (each, an “ Exempt Transfer ”) without first complying with this Section 5(b) and Sections 5(c) and 5(d) below to the extent that such sections apply to sales by such Stockholder. Prior to making any Transfer (other than an Exempt Transfer), the transferring Stockholder (the “ Transferring Stockholder ”) shall deliver written notice of the proposed Transfer (the “ Offer Notice ”) to the Company and each of the Investors and other Tag-Along Stockholders. The Offer Notice shall disclose in reasonable detail the proposed class and number of Stockholder Shares to be transferred or, in the case of a Transfer of Warrants, the class and number of Stockholder Shares issuable upon exercise of such Warrants, the proposed terms and conditions of the Transfer and the identity of the prospective transferree(s) (if known). No Stockholder shall consummate any Transfer until forty (40) days after the Offer Notice has been given to the Company and to each of the Investors, unless the parties to the Transfer have been finally determined pursuant to this Section 5 prior to the expiration of such 40-day period (the “ Election Period ”). The date of the first to occur of such events is referred to herein as the “ Authorization Date ”.

(c) First Offer Rights . First, the Company may elect to purchase all (but not less than all) of the Stockholder Shares or Warrants, as the case may be, specified in the Offer Notice at the price and on the same terms and conditions as those set forth in the Offer Notice by delivering a written notice of such election to the Transferring Stockholder and each Investor Group within twenty (20) days after the Offer Notice has been delivered to the Company. If the Company has not elected to purchase all Stockholder Shares or Warrants to be transferred within such twenty-day period, the Investor Groups may elect to purchase in the aggregate all (but not less than all) of the Stockholder Shares or Warrants, as the case may be, to be transferred (as applicable, the “ Available Shares ” or “ Available Warrants ”) at the price and on the same terms and conditions as those set forth in the Offer Notice by delivering written notice of such election to the Transferring Stockholder within thirty (30) days after the Offer Notice has been delivered to the Investor Groups. In the event that the Investor Groups in the aggregate elect to purchase more than the Available Shares or Available Warrants, as the case may be, then the number of Available Shares or Available Warrants to be purchased by each Investor Group that has elected to purchase more than its pro rata share of Available Shares or Available Warrants (based upon the number of Stockholder Shares (excluding Preferred Stock) held by all such Investor Groups) shall be reduced on a pro rata basis in proportion to the number of Stockholder Shares (excluding Preferred Stock) held by all Investor Groups that have elected to purchase more than their pro rata share that are not owned by such holder. Each Investor Group shall allocate the Stockholder Shares or Warrants so purchased among the Stockholders comprising such Investor Group pro rata according to the aggregate number of shares of such class of Stockholder Shares, or, in the case Warrants are purchased, according to the aggregate number of shares of the class of Stockholder Shares into which such Warrants are exercisable, held by each such Stockholder (on a fully diluted basis) or in such other manner as the Stockholders comprising such Investor Group shall from time to time agree. To the extent that the Company or the Investor Groups have not elected to purchase in the aggregate all of the Stockholder Shares or Warrants specified in the Offer Notice, the Transferring Stockholder may Transfer such Stockholder Shares or Warrants, as the case may be, to one or more third parties, subject to the provisions of Sections 5(d) and 5(f) below, at a price no less than the price per share or per Warrant, as applicable, specified in the Offer Notice and on terms no more favorable

 

7.


to the transferee(s) thereof than the terms offered to the Company and the Investor Groups in the Offer Notice during the 60-day period immediately following the Authorization Date. Any Stockholder Shares or Warrants not transferred within such 60-day period shall be reoffered to the Company and the Investor Groups under this Section 5(c) prior to any subsequent Transfer (that is subject to this Section 5(c)). If the Company or any of the Investor Groups have elected to purchase Stockholder Shares or Warrants hereunder, the Transfer of such shares or Warrants to the Company or the Investor Groups, as the case may be, shall be consummated as soon as practical after the delivery of the election notice(s) to the Transferring Stockholder, but in any event within fifteen (15) days after the expiration of the Election Period (it being understood that, if such Transfer to the Company or the Investor Groups, as the case may be, is not consummated within such 15-day period (other that as the result of actions or failures to act on the part of the Transferring Stockholder), the Transferring Stockholder shall be permitted to Transfer such Stockholder Shares or Warrants to one or more third parties during the 60-day period commencing on the 16 th day after the end of the Election Period on terms no more favorable to such transferee(s) than the terms offered to the Company and the Investor Groups pursuant to this Section 5(c)).

(d) Participation Rights . At least forty (40) days prior to any Transfer of Stockholder Shares (other than pursuant to a Public Sale or a Transfer to the Company or an Investor Group pursuant to Section 5(c) above and specifically excluding the Warrants and any Exempt Transfer), the Transferring Stockholder shall deliver a written notice (the “ Sale Notice ”) to the Company and each of the Tag-Along Stockholders (as defined below), specifying in reasonable detail the class and number of Stockholder Shares to be transferred, the proposed terms, and conditions of the proposed Transfer and the identity of the prospective transferee(s) (which notice may be the same notice and given at the same time as the Offer Notice under Section 5(c) above where applicable). If neither the Company nor the Investor Groups have elected to purchase all of the Stockholder Shares specified in the Sale Notice, each member of each Investor Group, each Qualifying Executive and each Warrantholder which holds Stockholder Shares of the class to be transferred or, in the case of any Warrantholder, holds Warrants exercisable for the class of shares to be transferred (collectively, the “ Tag-Along Stockholders ”), may elect to participate in the contemplated Transfer by delivering written notice (the “ Tag-Along Notice ”) to the Transferring Stockholder and the Company within 35 days after receipt by the Stockholders of the Sale Notice. If any Tag-Along Stockholder in addition to the Transferring Stockholder has elected to participate in such Transfer, the Transferring Stockholder and each such electing Tag-Along Stockholder shall be entitled to sell in the contemplated Transfer, at the same price per share and on the same terms, a number of Stockholder Shares of such class equal to the product of (i) the quotient determined by dividing the percentage of Stockholder Shares of such class held by such Person (assuming the exercise of all Warrants) by the aggregate percentage of Stockholder Shares of such class owned by the Transferring Stockholder and the Tag-Along Stockholders participating in such Transfer (assuming the exercise of all Warrants) and (ii) the number of Stockholder Shares of such class to be sold in the contemplated Transfer. Notwithstanding the foregoing, in the event that the Transferring Stockholder intends to Transfer more than one class of Stockholder Shares, each Tag-Along Stockholder participating in such Transfer shall be required to sell in the contemplated Transfer a pro rata portion of Stockholder Shares of all such classes (to the extent such Tag-Along Stockholder owns any shares of such other classes of Stockholder Shares or

 

8.


Warrants exercisable for shares of such other classes of Stockholder Shares), which portion shall be determined in the manner set forth immediately above.

For example , if the Sale Notice contemplated a sale of 100 shares of Common Stock by the Transferring Stockholder, and if the Transferring Stockholder at such time owns 30% of all shares of Common Stock and if one Tag-Along Stockholder elects to participate and owns 20% of all shares of Common Stock, the Transferring Stockholder would be entitled to sell 60 shares (30% ÷ 50% x 100 shares) and the Tag-Along Stockholder would be entitled to sell 40 shares (20% ÷ 50% x 100 shares).

The Transferring Stockholder shall use best efforts to obtain the agreement of the prospective transferee(s) to the participation of the Tag-Along Stockholders in the contemplated Transfer, and no Transferring Stockholder shall Transfer any Stockholder Shares to any prospective transferee(s) if such transferee(s) refuses to allow the participation of the Tag-Along Stockholders, unless the Transferring Stockholder offers to purchase from each Tag-Along Stockholder (immediately following the Transferring Stockholder’s Transfer to such transferee(s)), such number and class of Stockholder Shares as the given Tag-Along Stockholder elected to sell in the Transfer pursuant to this Section 5(d), in each case on the same terms and conditions as the Transferring Stockholder transferred its Stockholder Shares.

Any Tag-Along Stockholder participating in the contemplated Transfer which does not hold enough Stockholder Shares of a particular class to cover the number of Stockholder Shares of such class which such Tag-Along Stockholder proposes to include in such Transfer but which holds Warrants exercisable for additional Stockholder Shares of such class shall, as a condition to participating in such Transfer, exercise its Warrants for a number of Stockholder Shares of such class equal to the number of Stockholder Shares of such class being Transferred by such Tag-Along Stockholder pursuant to this Section 5(d) less the number of Stockholder Shares of such class which such Tag-Along Stockholder holds and intends to include in the Transfer (it being understood that, if such Transfer is not consummated, such Tag-Along Stockholder shall be entitled to rescind its exercise and to receive replacement Warrants for the Warrants exercised in anticipation of such Transfer).

(e) Certain Permitted Transfers . The restrictions contained in this Section 5 shall not apply with respect to Transfers of Stockholder Shares or Warrants (i) in the case of an Executive, (A) by will or pursuant to applicable laws of descent and distribution and among Executive’s family group, or (B) to the Company upon a repurchase of such Stockholder Shares by the Company in accordance with any of the Company’s stock option plans and any stock option agreement thereunder, (ii) in the case of an Investor or a Warrantholder, among its Affiliates and (iii) in the case of any Warrantholder, in connection with (A) any Transfer to any other Lender under the Credit Agreement (as hereinafter defined) or (B) any Transfer deemed necessary to comply with any requirement of law, regulation or order or request from a regulatory authority; provided that such restrictions shall continue to be applicable to Stockholder Shares or Warrants, as the case may be, after any such Transfer and the transferees of such Stockholder Shares or Warrants (“ Permitted Transferees ”) shall have agreed in writing to be bound by the provisions of this Agreement. An Executive’s “family group” means such executive’s spouse and descendants (whether natural or adopted) and any trust solely for the

 

9.


benefit of such Executive and/or such executive’s spouse and/or descendants. Notwithstanding the foregoing, no party hereto shall avoid the provisions of this Agreement by making one or more Transfers to one or more Permitted Transferees and then disposing of all or any portion of such party’s interest in any such Permitted Transferee.

(f) Recapitalization Treatment. Notwithstanding anything contained in this Section 5 to the contrary, in connection with any Transfer of Stockholder Shares (other than shares received upon the exercise of the Warrants) by a Stockholder (or a Permitted Transferee) in accordance with the terms and conditions contained in this Agreement (other than pursuant to Section 7 below prior to a Public Offering), such Stockholder (or such Permitted Transferee) shall cause to be provided to the Stockholder of each Investor Group holding the largest number of Stockholder Shares such information as is necessary for each such Stockholder to be satisfied in its sole discretion that, after giving effect to such Transfer, the transactions contemplated hereby and in the other Transaction Documents, when viewed collectively, shall continue to qualify as a recapitalization for accounting purposes and each such Stockholder shall have received such opinions and advice as it deems necessary from the Company’s accountants and advisers as to such recapitalization treatment. No Stockholder (or Permitted Transferee) shall Transfer any Stockholder Shares unless and until all conditions set forth in the preceding sentence are satisfied to the satisfaction of the Stockholder of each Investor Group holding the largest number of Stockholder Shares in its sole discretion.

(g) Termination of Restrictions . The restrictions on the Transfer of Stockholder Shares and Warrants set forth in this Section 5 shall continue with respect to each Stockholder Share and each Warrant following any Transfer thereof (other than pursuant to a Public Sale or a Sale of the Company); provided that in any event such restrictions shall terminate on the first to occur of a Sale of the Company or (other than with respect to the Executives) a Qualified Public Offering and, with respect to the Executives, 15 months following a Qualified Public Offering.

6. Legend . Each certificate evidencing Stockholder Shares or Warrants and each certificate issued upon exercise of the Warrants or in exchange for or upon the transfer of any Stockholder Shares or Warrants (if such shares remain Stockholder Shares or Warrants as defined herein after such transfer) shall be stamped or otherwise imprinted with a legend in substantially the following form:

“The securities represented hereby have not been registered under the Securities Act of 1933, as amended (the “Act”) and may not be sold or transferred in the absence of an effective registration statement under the Act or an exemption from registration thereunder. The securities represented by this certificate are also subject to a Second Amended and Restated Stockholders Agreement dated as of March 25, 2003, among the issuer of such securities (the “Company”) and certain of the Company’s equityholders, as further amended and modified from time to time in accordance with its terms. A copy of such Stockholders Agreement will be furnished without charge by the Company to the holder hereof upon written request.”

 

10.


The Company shall imprint such legend on certificates evidencing Stockholder Shares and Warrants outstanding prior to the date here


 
SITE SEARCH

AGREEMENTS / CONTRACTS

Document Title:

Entire Document: (optional)

Governing Law:(optional)


Try our advanced search >>
 

CLAUSES

Search Contract Clauses >>

Browse Contract Clause Library>>

Get Email Updates
Email:
This is only a partial view of this document. We have millions of legal documents and clauses drafted by top law firms. learn more search for free browse for free learn more